Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Critical roles of TRAIL in hepatic cell death and hepatic inflammation
Shi-Jun Zheng, … , Galit Tsabary, Youhai H. Chen
Shi-Jun Zheng, … , Galit Tsabary, Youhai H. Chen
Published January 1, 2004
Citation Information: J Clin Invest. 2004;113(1):58-64. https://doi.org/10.1172/JCI19255.
View: Text | PDF
Article Immunology

Critical roles of TRAIL in hepatic cell death and hepatic inflammation

  • Text
  • PDF
Abstract

The TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis of tumor cells but not most normal cells. Its role in hepatic cell death and hepatic diseases is not clear. In vitro studies suggest that murine hepatocytes are not sensitive to TRAIL-induced apoptosis, indicating that TRAIL may not mediate hepatic cell death. Using two experimental models of hepatitis, we found that hepatic cell death in vivo was dramatically reduced in TRAIL-deficient mice and mice treated with a blocking TRAIL receptor. Although both TRAIL and its death receptor 5 were constitutively expressed in the liver, TRAIL expression by immune cells alone was sufficient to restore the sensitivity of TRAIL-deficient mice to hepatitis. Thus, TRAIL plays a crucial role in hepatic cell death and hepatic inflammation.

Authors

Shi-Jun Zheng, Pu Wang, Galit Tsabary, Youhai H. Chen

×

Total citations by year

Year: 2025 2024 2023 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Total
Citations: 1 3 1 3 4 7 2 3 3 4 3 1 5 7 4 7 4 3 1 66
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (66)

Title and authors Publication Year
Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus
Fukumoto M, Soyama A, Miyamoto D, Hara T, Matsushima H, Imamura H, Yamashita M, Adachi T, Kanetaka K, Eguchi S
Regenerative Therapy 2025
TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A, Micheau O
Cells 2024
RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives
Monti F, Perazza F, Leoni L, Stefanini B, Ferri S, Tovoli F, Zavatta G, Piscaglia F, Petroni ML, Ravaioli F
International Journal of Molecular Sciences 2024
Advancing Systemic Therapy in Chondrosarcoma: New Horizons
Li KH, Gulia A, Duffaud F, Jones RL
Oncology and Therapy 2024
LIGHT Amplification by NF-κB Contributes to TLR3 Signaling Pathway-Induced Acute Hepatitis
Lai D, Lv Z, Lu X, Shang P, Geng Y, Wang P
Mediators of Inflammation 2023
Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice
T Affolter, HP Llewellyn, DW Bartlett, Q Zong, S Xia, V Torti, C Ji, P Mukhopadhyay
PloS one 2019
Preclinical studies of a death receptor 5 fusion protein that ameliorates acute liver failure
Q Chen, P Wang, Q Zhang, M Xia, G Zhang, J Li, E Shen, YH Chen, X Wan
Journal of Molecular Medicine 2019
Non‐apoptotic TRAIL function modulates NK cell activity during viral infection
LC Alves, MD Berger, T Koutsandreas, N Kirschke, C Lauer, R Spörri, A Chatziioannou, N Corazza, P Krebs
EMBO reports 2019
Hepatoprotective Effect of San-Cao Granule on Con A-Induced Liver Injury in Mice and Mechanisms of Action Exploration
YX Yang, P Zhang, Y Wang, S Wei, L Zhang, J Wang, X Lu, H Zhou, R Li, J Wen, X Zhou, H Li, K Li, Y Zhao
Frontiers in pharmacology 2018
CEACAM1 in Liver Injury, Metabolic and Immune Regulation
A Horst, S Najjar, C Wagener, G Tiegs
International journal of molecular sciences 2018
Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis.
Qian H, Chen Y, Huang T, Liu T, Li X, Jiang G, Zhang W, Cheng S, Li P
Oncology Letters 2018
Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy.
Mf Akbar S, Al-Mahtab M, I Khan S
Euroasian Journal of Hepato-Gastroenterology 2018
RIPK1 protects hepatocytes from death in Fas-induced hepatitis
A Filliol, M Farooq, C Piquet-Pellorce, V Genet, MT Dimanche-Boitrel, P Vandenabeele, MJ Bertrand, M Samson, JL Seyec
Scientific Reports 2017
The apoptotic mechanisms of MT-6, a mitotic arrest inducer, in human ovarian cancer cells
MC Chen, YC Kuo, CM Hsu, YL Chen, CC Shen, CM Teng, SL Pan
Scientific Reports 2017
Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells
S Sydor, S Jafoui, L Wingerter, S Swoboda, JC Mertens, G Gerken, A Canbay, A Paul, CD Fingas
World journal of gastroenterology : WJG 2017
Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
W Wu, L Lv, D Shi, J Ye, D Fang, F Guo, Y Li, X He, L Li
Frontiers in microbiology 2017
Analyzing the innate immunity of NIH hairless mice and the impact of gut microbial polymorphisms on Listeria monocytogenes infection
ZH Ji, WZ Ren, W Gao, Y Hao, W Gao, J Chen, FS Quan, JP Hu, B Yuan
Oncotarget 2017
Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect
JY Kim, YM Kim, JM Park, YM Han, KC Lee, KB Hahm, S Hong
Oncotarget 2017
Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance
Khan HA, Ahmad MZ, Khan JA, Arshad MI
Hepatobiliary & Pancreatic Diseases International 2017
Super natural killer cells that target metastases in the tumor draining lymph nodes
S Chandrasekaran, MF Chan, J Li, MR King
Biomaterials 2016
Questions and controversies: the role of necroptosis in liver disease
L Dara, ZX Liu, N Kaplowitz
Cell Death Discovery 2016
The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver
MI Arshad, C Piquet-Pellorce, A Filliol, A L’Helgoualc’h, C Lucas-Clerc, S Jouan-Lanhouet, MT Dimanche-Boitrel, M Samson
Journal of Molecular Medicine 2015
Cinnabar-Induced Subchronic Renal Injury Is Associated with Increased Apoptosis in Rats
Y Wang, D Wang, J Wu, B Wang, X Gao, L Wang, H Ma
BioMed Research International 2015
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles
J Li, Y Ai, L Wang, P Bu, CC Sharkey, Q Wu, B Wun, S Roy, X Shen, MR King
Biomaterials 2015
HCV and HIV co-infection: mechanisms and management
JY Chen, ER Feeney, RT Chung
Nature Reviews Gastroenterology & Hepatology 2014
The C5a Anaphylatoxin Receptor (C5aR1) Protects against Listeria monocytogenes Infection by Inhibiting Type 1 IFN Expression
DG Calame, SL Mueller-Ortiz, JE Morales, RA Wetsel
Journal of immunology (Baltimore, Md. : 1950) 2014
Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122.
Zhou K, Yan Y, Zhao S
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014
TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma
M Keuper, IW Asterholm, PE Scherer, MA Westhoff, P Möller, KM Debatin, G Strauss, M Wabitsch, P Fischer-Posovszky
Cell Death and Disease 2013
Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy
F Qiu, M Hu, B Tang, X Liu, H Zhuang, J Yang, ZC Hua
Scientific Reports 2013
NK cells: a double-edged sword in chronic hepatitis B virus infection
MK Maini, D Peppa
Frontiers in immunology 2013
Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury
T Adachi, N Sugiyama, T Gondai, H Yagita, T Yokoyama
ACTA HISTOCHEMICA ET CYTOCHEMICA 2013
Resistance to TRAIL and how to surmount it
D Maksimovic-Ivanic, S Stosic-Grujicic, F Nicoletti, S Mijatovic
Immunologic Research 2012
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S Jouan-Lanhouet, MI Arshad, C Piquet-Pellorce, C Martin-Chouly, GL Moigne-Muller, FV Herreweghe, N Takahashi, O Sergent, D Lagadic-Gossmann, P Vandenabeele, M Samson, MT Dimanche-Boitrel
Cell Death and Differentiation 2012
The role of innate immunity in HBV infection
Q Han, C Zhang, J Zhang, Z Tian
Seminars in Immunopathology 2012
HIV-1 Coinfection and Morphine Coexposure Severely Dysregulate Hepatitis C Virus-Induced Hepatic Proinflammatory Cytokine Release and Free Radical Production: Increased Pathogenesis Coincides with Uncoordinated Host Defenses
N El-Hage, SM Dever, S Fitting, T Ahmed, KF Hauser
Journal of virology 2011
TNF superfamily: a growing saga of kidney injury modulators
MD Sanchez-Niño, A Benito-Martin, S Gonçalves, AB Sanz, AC Ucero, MC Izquierdo, AM Ramos, S Berzal, R Selgas, M Ruiz-Ortega, J Egido, A Ortiz
Mediators of Inflammation 2010
Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo
M Nagane, S Shimizu, E Mori, S Kataoka, Y Shiokawa
Neuro-Oncology 2010
Control of death receptor ligand activity by posttranslational modifications
R Weinlich, T Brunner, GP Amarante-Mendes
Cellular and Molecular Life Sciences 2010
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
T Trarbach, M Moehler, V Heinemann, CH Köhne, M Przyborek, C Schulz, V Sneller, G Gallant, S Kanzler
British Journal of Cancer 2010
Sepsis-Induced Apoptosis Leads to Active Suppression of Delayed-Type Hypersensitivity by CD8 + Regulatory T Cells through a TRAIL-Dependent Mechanism
J Unsinger, H Kazama, JS McDonough, TS Griffith, RS Hotchkiss, TA Ferguson
Journal of immunology (Baltimore, Md. : 1950) 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation
O Hoffmann, F Zipp, JR Weber
Journal of Molecular Medicine 2009
Immune cell-mediated liver injury
N Corazza, A Badmann, C Lauer
Seminars in Immunopathology 2009
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
S Ganai, RB Arenas, NS Forbes
British Journal of Cancer 2009
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage
N Beraza, Y Malato, LE Sander, M Al-Masaoudi, J Freimuth, D Riethmacher, GJ Gores, T Roskams, C Liedtke, C Trautwein
Journal of Experimental Medicine 2009
Caspase inhibitors for the treatment of hepatitis C
HC Masuoka, ME Guicciardi, GJ Gores
Clinics in Liver Disease 2009
The TRAIL to Viral Pathogenesis: The Good, the Bad and the Ugly
Cummins N, Badley A
Current molecular medicine 2009
Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice
HM Ni, X Chen, WX Ding, M Schuchmann, XM Yin
The American Journal of Pathology 2008
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
K Takeda, Y Kojima, K Ikejima, K Harada, S Yamashina, K Okumura, T Aoyama, S Frese, H Ikeda, NM Haynes, E Cretney, H Yagita, N Sueyoshi, N Sato, Y Nakanuma, MJ Smyth, K Okumura
Proceedings of the National Academy of Sciences 2008
Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5
JB Fiveash, GY Gillespie, PG Oliver, T Zhou, ML Belenky, DJ Buchsbaum
International journal of radiation oncology, biology, physics 2008
TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help.
Sacks JA, Bevan MJ
Journal of immunology (Baltimore, Md. : 1950) 2008
TRAIL-R knockout promotes susceptibility to chronic inflammation and tumorigenesis
Niklas Finnberg, Andres J.P. Klein-Szanto and Wafik S. El-Deiry
Journal of Clinical Investigation 2007
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
C Dunn, M Brunetto, G Reynolds, T Christophides, PT Kennedy, P Lampertico, A Das, AR Lopes, P Borrow, K Williams, E Humphreys, S Afford, DH Adams, A Bertoletti, MK Maini
Journal of Experimental Medicine 2007
CCR5 Deficiency Drives Enhanced Natural Killer Cell Trafficking to and Activation within the Liver in Murine T Cell-Mediated Hepatitis
MN Ajuebor, Z Wondimu, CM Hogaboam, T Le, AE Proudfoot, MG Swain
The American Journal of Pathology 2007
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
H Malhi, FJ Barreyro, H Isomoto, SF Bronk, GJ Gores
Gut 2007
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C
N Pelli, A Floreani, F Torre, A Delfino, A Baragiotta, P Contini, M Basso, A Picciotto
Clinical & Experimental Immunology 2007
Hepatitis C virus infection and apoptosis
Fischer R, Baumert T, Blum HE
World journal of gastroenterology : WJG 2007
Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.
Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon B, Chen L, Vella AT, Mittler RS
Journal of immunology (Baltimore, Md. : 1950) 2007
Essential Role of TNF family molecule LIGHT as a Cytokine in the Pathogenesis of Hepatitis
Sudarshan Anand, Pu Wang, Kiyoshi Yoshimura, In-Hak Choi, Anja Hilliard, Youhai H. Chen, Chyung-Ru Wang, Richard Schulick, Andrew S. Flies, Dallas B. Flies, Gefeng Zhu, Yanhui Xu, Drew M. Pardoll, Lieping Chen and Koji Tamada
Journal of Clinical Investigation 2006
TRAIL receptor-mediated Jun kinase activation and Bim phosphorylation critically regulate Fas (CD95)-mediated liver damage and lethality
Nadia Corazza, Sabine Jakob, Corinne Schaer, Steffen Frese, Adrian Keogh, Deborah Stroka, Daniela Kassahn, Ralph Torgler, Christoph Mueller, Pascal Schneider, Thomas Brunner
Journal of Clinical Investigation 2006
Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity
GC Ulett, EE Adderson
Current immunology reviews 2006
Mac-1 + Cells Are the Predominant Subset in the Early Hepatic Lesions of Mice Infected with Francisella tularensis
JW Rasmussen, J Cello, H Gil, CA Forestal, MB Furie, DG Thanassi, JL Benach
Infection and immunity 2006
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake
B Mundt, T Wirth, L Zender, M Waltemathe, C Trautwein, MP Manns, F Kühnel, S Kubicka
Gut 2005
Following the TRAIL from hepatitis C virus and alcohol to fatty liver
SC Afford, DH Adams
Gut 2005
Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.
Yang X, Wang J, Liu C, Grizzle WE, Yu S, Zhang S, Barnes S, Koopman WJ, Mountz JD, Kimberly RP, Zhang HG
The American Journal of Pathology 2005
TRAIL and its receptors as targets for cancer therapy
H Yagita, K Takeda, Y Hayakawa, MJ Smyth, K Okumura
Cancer Science 2004

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts